Tenascin-C enhances crosstalk signaling of integrin αvβ3/PDGFR-β complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2617-2624

  Ishigaki, Tomoki ^a   Imanaka Yoshida, Kyoko ^a   Shimojo, Naoshi ^a   Matsushima, Satoshi ^a   Taki, Waro ^a   Yoshida, Toshimichi ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ALPHA5BETA3 INTEGRIN ANTIBODY; BROXURIDINE; FOCAL ADHESION KINASE; INTEGRIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN ANTIBODY; PROTEIN TYROSINE KINASE; TENASCIN; TYROSINE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL ADHESION; CELL ASSAY; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; FOCAL ADHESION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA, THORACIC; CELL LINE; CELL PROLIFERATION; CHEMOTAXIS; INTEGRIN ALPHAVBETA3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RATS; RECEPTOR CROSS-TALK; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TENASCIN; UP-REGULATION;

RATTUS;

EID: 79960675151     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22614     Document Type: Article

References (49)

1. Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. 2003. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA 100: 13298-13302.
2. Barrett TB, Benditt EP. 1987. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA 84: 1099-1103.
3. Bendeck MP, Irvin C, Reidy M, Smith L, Mulholland D, Horton M, Giachelli CM. 2000. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. Arterioscler Thromb Vasc Biol 20: 1467-1472.
4. Brunton VG, Frame MC. 2008. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 8: 427-432.
5. Cox BD, Natarajan M, Stettner MR, Gladson CL. 2006. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 99: 35-52.
6. Davies MG, Hagen PO. 1994. Pathobiology of intimal hyperplasia. Br J Surg 81: 1254-1269.
7. Ding Q, Grammer JR, Nelson MA, Guan JL, Stewart JE Jr, Gladson CL. 2005. p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain. J Biol Chem 280: 6802-6815.
8. Eliceiri BP. 2001. Integrin and growth factor receptor crosstalk. Circ Res 89: 1104-1110.
9. Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science 285: 1028-1032.
10. Guarino M. 2010. Src signaling in cancer invasion. J Cell Physiol 223: 14-26.
11. Hedin U, Holm J, Hansson GK. 1991. Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype. Am J Pathol 139: 649-656.
12. Heldin CH, Ostman A, Ronnstrand L. 1998. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-F113.
13. Hollenbeck ST, Itoh H, Louie O, Faries PL, Liu B, Kent KC. 2004. Type I collagen synergistically enhances PDGF-induced smooth muscle cell proliferation through pp60src-dependent crosstalk between the alpha2beta1 integrin and PDGFbeta receptor. Biochem Biophys Res Commun 325: 328-337.
14. Huveneers S, Danen EH. 2009. Adhesion signaling-Crosstalk between integrins, Src and Rho. J Cell Sci 122: 1059-1069.
15. Imanaka-Yoshida K, Matsuura R, Isaka N, Nakano T, Sakakura T, Yoshida T. 2001. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: Clinical significance of early tenascin-C expression. Virchows Arch 439: 185-190.
16. Imanaka-Yoshida K, Hiroe M, Yasutomi Y, Toyozaki T, Tsuchiya T, Noda N, Maki T, Nishikawa T, Sakakura T, Yoshida T. 2002. Tenascin-C is a useful marker for disease activity in myocarditis. J Pathol 197: 388-394.
17. Jones PL, Rabinovitch M. 1996. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res 79: 1131-1142.
18. Jones PL, Crack J, Rabinovitch M. 1997. Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139: 279-293.
19. LaFleur DW, Fagin JA, Forrester JS, Rubin SA, Sharifi BG. 1994. Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. J Biol Chem 269: 20757-20763.
20. Luo M, Guan JL. 2010. Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289: 127-139.
21. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, Buhler FR. 1992. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 141: 377-388.
22. McKean DM, Sisbarro L, Ilic D, Kaplan-Alburquerque N, Nemenoff R, Weiser-Evans M, Kern MJ, Jones PL. 2003. FAK induces expression of Prx1 to promote tenascin-C-dependent fibroblast migration. J Cell Biol 161: 393-402.
23. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC. 2005. The role of focal-adhesion kinase in cancer-A new therapeutic opportunity. Nat Rev Cancer 5: 505-515.
24. Midwood KS, Orend G. 2009. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3: 287-310.
25. Mitra SK, Schlaepfer DD. 2006. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523.
26. Mori S, Ronnstrand L, Yokote K, Engstrom A, Courtneidge SA, Claesson-Welsh L, Heldin CH. 1993. Identification of two juxtamembrane autophosphorylation sites in the PDGF beta-receptor; involvement in the interaction with Src family tyrosine kinases. EMBO J 12: 2257-2264.
27. Orend G, Chiquet-Ehrismann R. 2006. Tenascin-C induced signaling in cancer. Cancer Lett 244: 143-163.
28. Perlstein I, Connolly JM, Cui X, Song C, Li Q, Jones PL, Lu Z, DeFelice S, Klugherz B, Wilensky R, Levy RJ. 2003. DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: Mechanisms of enhanced transfection. Gene Ther 10: 1420-1428.
29. Raines EW. 2004. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 15: 237-254.
30. Rao RS, Miano JM, Olson EN, Seidel CL. 1997. The A10 cell line: A model for neonatal, neointimal, or differentiated vascular smooth muscle cells? Cardiovasc Res 36: 118-126.
31. Ross R. 1993. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809.
32. Roy A, Volgin DV, Baby SM, Mokashi A, Kubin L, Lahiri S. 2004. Activation of HIF-1alpha mRNA by hypoxia and iron chelator in isolated rat carotid body. Neurosci Lett 363: 229-232.
33. Rubin K, Tingstrom A, Hansson GK, Larsson E, Ronnstrand L, Klareskog L, Claesson-Welsh L, Heldin CH, Fellstrom B, Terracio L. 1988. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions. Lancet 1: 1353-1356.
34. Sawada Y, Onoda K, Imanaka-Yoshida K, Maruyama J, Yamamoto K, Yoshida T, Shimpo H. 2007. Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis. Cardiovasc Res 74: 366-376.
35. Schneller M, Vuori K, Ruoslahti E. 1997. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J 16: 5600-5607.
36. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T. 2005. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 167: 71-80.
37. Tanizawa S, Ueda M, van der Loos CM, van der Wal AC, Becker AE. 1996. Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: An immunohistochemical study. Heart 75: 549-556.
38. Toma N, Matsushima S, Murao K, Kawaguchi K, Imanaka-Yoshida K, Yoshida T, Taki W. 2003. Histopathological findings in a human carotid artery after stent implantation. Case report. J Neurosurg 98: 199-204.
39. Toma N, Imanaka-Yoshida K, Takeuchi T, Matsushima S, Iwata H, Yoshida T, Taki W. 2005. Tenascin-C-coated platinum coils for acceleration of organization of cavities and reduction of lumen size in a rat aneurysm model. J Neurosurg 103: 681-686.
40. Trebaul A, Chan EK, Midwood KS. 2007. Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans 35: 695-697.
41. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T. 2003. Involvement of large tenascin-C splice variants in breast cancer progression. Am J Pathol 162: 1857-1867.
42. Wallner K, Shah PK, Sharifi BG. 2002. Balloon catheterization induces arterial expression of new Tenascin-C isoform. Atherosclerosis 161: 75-83.
43. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. 1988. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 82: 1134-1143.
44. Woodard AS, Garcia-Cardena G, Leong M, Madri JA, Sessa WC, Languino LR. 1998. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci 111: 469-478.
45. Wu L, Bernard-Trifilo JA, Lim Y, Lim ST, Mitra SK, Uryu S, Chen M, Pallen CJ, Cheung NK, Mikolon D, Mielgo A, Stupack DG, Schlaepfer DD. 2008. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility. Oncogene 27: 1439-1448.
46. Yamamoto K, Onoda K, Sawada Y, Fujinaga K, Imanaka-Yoshida K, Shimpo H, Yoshida T, Yada I. 2005. Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice. Cardiovasc Res 65: 737-742.
47. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. 1999. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch 435: 496-500.
48. Zagzag D, Shiff B, Jallo GI, Greco MA, Blanco C, Cohen H, Hukin J, Allen JC, Friedlander DR. 2002. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 62: 2660-2668.
49. Zhao JH, Reiske H, Guan JL. 1998. Regulation of the cell cycle by focal adhesion kinase. J Cell Biol 143: 1997-2008.